Introduction: Focal Segmental Glomerulosclerosis (FSGS) corresponds to a clinicopathological syndrome, manifested by generally abundant proteinuria associated with hyaline deposits on part of certain glomeruli and sparing other glomeruli, with effacement of the pedicels. The general objective was to determine the prevalence of FSGS, and to give its profiles; epidemiological, clinical, biological, pathological, etiological, therapeutic and evolutionary of FSGS. Materials and Methods: This is a retrospective analytical study over a period of six years extending from January 1, 2010 to December 31, 2015 patients aged 16 or over who were hospitalized or received consultations during the study period for primary or secondary segmental and focal hyalinosis. Patients whose records were incomplete or unusable were not included in the study. Results: We have 16.54% with 158 cases of FSGS out of 6945 patients received and/or hospitalized. Of the 955 kidney biopsies distributed, the incidences of HSF were; 10.15%; 14.04%; 15%; 17.64%; 20.11%; 19.58% respectively in 2010; 2011; 2012; 2013; 2014 and 2015, i.e. an annual increase of around 1.25%. Renal-type edemas were found in 93.3%, the first reason for hospitalization. And ninety-six people had impaired kidney function, or 61%. The average of 24-hour proteinuria was 6.4 ± 3.69 g/24 hours. The extremes were 0.37 and 18.50 g/24h. Patients had nephrotic proteinuria in 84.86%. Non-specific FSGS or NOS (Not Other Specificities) was found in 62 cases or 39.24%, collapsing FSGS in 48 cases or 30.40%. FSGS with found causes was associated with fibrosis in 5/35 cases. Collapsing FSGSs followed by NOS FSGSs were the most corticosteroid-resistant. The evolution of the FSGS reveals that every 8 months the proteinuria decreases by half. Conclusion: Segmental and focal hyalinosis requires histological confirmation and the epidemiological, clinico-biological, etiological, therapeutic and evolutionary profiles depend on the histological (pathological) type. Other works on the risk factors for occurrence and the contribution of electron microscopy in the primary and secondary diagnosis of segmental and focal hyalinosis are desired.
References
[1]
Richet, G. (2000) The Society of Renal Pathology (1948-1949). Nephrology, 21, 23-26. (In French)
[2]
Davison, A.M. and Johnston, P.A. (1996) Glomerulonephritis in the Elderly. Nephrology Dialysis Transplantation, 11, 34-37. https://doi.org/10.1093/ndt/11.supp9.34
[3]
Van Rensburg, B.W.J., van Staden, A.M., Rossouw, G.J. and Joubert, G. (2010) The Profile of Adult Nephrology Patients Admitted to the Renal Unit of the Universitas Tertiary Hospital in Bloemfontein, South Africa from 1997 to 2006. Nephrology Dialysis Transplantation, 25, 820-824. https://doi.org/10.1093/ndt/gfp535
[4]
Malafronte, P., Mastroianni-Kirsztajn, G., Betônico, G.N., et al. (2006) Paulista Registry of Glomerulonephritis: 5-Year Data Report. Nephrology Dialysis Transplantation, 21, 3098-3105. https://doi.org/10.1093/ndt/gfl237
[5]
Cherif, M.M.D. (2002) Segmental and Focal Hyalinosis in Dakar: Epidemiological, Clinical, Paraclinical and Evolutionary Aspects between January and December 2001 in the Internal Medicine Department of the Aristide Le Dantec Hospital. Medical Thesis, Cheikh Anta Diop University, Dakar.
[6]
Segarra, A., Vila, J., Majo, J., et al. (2002) Combined Therapy of Tacrolimus and Corticosteroids in Cyclosporine-Resistant or -Dependent Idiopathic Focal Glomerulosclerosis: A Preliminary Uncontrolled Study with Prospective Follow-Up. Nephrology Dialysis Transplantation, 17, 655-662. https://doi.org/10.1093/ndt/17.4.655
[7]
Weehrmann, M., Bohle, A., Held, H., Schumm, G., Kendziorra, H. and Pressler, H. (1996) Long-Term Prognosis of Focal Sclerosing Glomerulonephritis: An Analysis of 250 Cases with Particular. Kidney International, 50, 1734-1746.
[8]
Haas, M., Spargo, B.H. and Coventry, S. (1995) Increasing Incidence of Focal-Segmental Glomerulosclerosis among Adult Nephropathies: A 20-Year Renal Biopsy Study. American Journal of Kidney Diseases, 26, 740-750. https://doi.org/10.1016/0272-6386(95)90437-9
[9]
Briganti, E.M., Dowling, J., Finlay, M., et al. (2001) The Incidence of Biopsy-Proven Glomerulonephritis in Australia. Nephrology Dialysis Transplantation, 16, 1364-1367. https://doi.org/10.1093/ndt/16.7.1364
[10]
Narasimhan, B., Chacko, B., John, G., Korula, A., Kirubakaran, M. and Jacob, C.K. (2006) Characterization of Kidney Lesions in Indian Adults: Towards a Renal Biopsy Registry. Journal of Nephrology, 19, 205-210.
[11]
Djibrilla, G.T. (2012) Watered Nephropathy: Epidemiological and Anatomo-Clinical Aspects of a Series of 375 Renal Biopsies Performed in DAKAR from 1 to 31 AUGUST. Thesis, Cheikh Anta Diop University, Dakar.
[12]
Detwiler, R.K., Falk, R.I., Hogan, S.L., et al. (1994) Collapsing Glomerulopathy: A Clinically and Pathologically Distinct Variant of Focal Segmental Glomerulosclerosis. Kidney International, 45, 1416-1424. https://doi.org/10.1038/ki.1994.185
[13]
Weiss, M.A., Daquioag, E., Margolin, E.G., et al. (1986) Nephrotic Syndrome, Progressive Irreversible Renal Failure, and Glomerular “Collapse”: A New Clinical Pathology Entity? American Journal of Kidney Diseases, 7, 20-28. https://doi.org/10.1016/S0272-6386(86)80052-X
[14]
Velosa, J.A., Holley, K.E., Offord, K.P., et al. (1983) Significance of Proteinuria on the Outcome of Renal Function in Patients with Focal Segmental Glomerulosclerosis. Mayo Clinic Proceedings, 58, 568-577.
[15]
Pichler, R., Giachelle, C.M., Lombardi, D., et al. (1994) Tubulointerstitial Disease in Glomerulonephritis. The American Journal of Pathology, 33, 915-926.
[16]
Pei, A.Y., Catrran, D. and Greenwood, C. (1992) Predicting Chronic Renal Insufficiency in Idiopathic Membranous Glomerulonephritis. Kidney International, 42, 960-966. https://doi.org/10.1038/ki.1992.374
[17]
Tarshish, P., Bernstein. J., Tobin, J. and Jr Edelmann, C.M. (1992) Treatment of Mesangiocapillary Glomerulonephritis with Alternate-Day Prednisone: A Report of the International Study of Kidney Disease in Children. Pediatric Nephrology, 6, 123-130. https://doi.org/10.1007/BF00866289
[18]
Mendoza, S. (1999) Treatment of Idiopathic Syndrome. Therapeutic Medicine, 2, 451-456.
[19]
Pei, A.Y., et al. (1999) Extramembranous Glomerulonephritis. What Treatment? Therapeutic. Medicine, 5, 371-376.
[20]
Miao, J., Krisanapan, P., Tangpanithandee, S., Thongprayoon, C., Mao, M.A. and Cheungpasitporn, W. (2023) Efficacy of Extracorporeal Plasma Therapy for Adult Native Kidney Patients with Primary FSGS: A Systematic Review. Renal Failure, 45, Article ID: 2176694. https://doi.org/10.1080/0886022X.2023.2176694
[21]
Osterholt, T., Todorova, P., Kühne, L. et al. (2023) Repetitive Administration of Rituximab Can Achieve and Maintain Clinical Remission in Patients with MCD or FSGS. Scientific Reports, 13, Article No. 6980. https://doi.org/10.1038/s41598-023-32576-7
[22]
Gebeshuber, C.A., Daniel-Fischer, L., Regele, H., Schachner, H., Aufricht, C., Kornauth, C., et al. (2023) Computational Drug Repositioning of Clopidogrel as a Novel Therapeutic Option for Focal Segmental Glomerulosclerosis. Translational Research, (In Press) https://doi.org/10.1016/j.trsl.2023.04.001
